in vitro PHARMACOLOGY 2011 CATALOG - Cerep
in vitro PHARMACOLOGY 2011 CATALOG - Cerep
in vitro PHARMACOLOGY 2011 CATALOG - Cerep
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
100 <strong>in</strong> <strong>vitro</strong> pharmacology <strong>2011</strong> catalog<br />
❚ nicot<strong>in</strong>ic channels<br />
N muscle-type - antagonist radioligand<br />
b<strong>in</strong>d<strong>in</strong>g<br />
Ref. 0936<br />
Q 3 weeks<br />
Included <strong>in</strong>:<br />
BioPr<strong>in</strong>t ® profile<br />
Source<br />
Ligand<br />
Kd<br />
Non specific<br />
Reference<br />
TE671 cells (endogenous)<br />
N neuronal (a4b2) - agonist radioligand<br />
b<strong>in</strong>d<strong>in</strong>g<br />
Ref. 3029<br />
Q 3 weeks<br />
Included <strong>in</strong>:<br />
Diversity profile<br />
BioPr<strong>in</strong>t ® profile<br />
Organ safety profile<br />
[ 125 I]α-bungarotox<strong>in</strong> (0.5 nM)<br />
9.5 nM<br />
α-bungarotox<strong>in</strong> (5 µM)<br />
α-bungarotox<strong>in</strong> (IC 50 : 14 nM)<br />
specific b<strong>in</strong>d<strong>in</strong>g (% of control)<br />
100<br />
50<br />
0<br />
-10 -9 -8 -7 -6 -5 -4<br />
log [drug] (M)<br />
α-bungarotox<strong>in</strong><br />
tubocurar<strong>in</strong>e<br />
nicot<strong>in</strong>e<br />
atrop<strong>in</strong>e<br />
Lukas, R.J. (1986) J. Neurochem., 46: 1936-1941.<br />
[Custom offer] mouse BC3H1 cells model (Ref. 0111), please contact us at customresearch@cerep.com<br />
Source<br />
Ligand<br />
Kd (nM)<br />
Non specific<br />
Reference<br />
SH-SY5Y cells (endogenous)<br />
[ 3 H]cytis<strong>in</strong>e (0.6 nM)<br />
0.3 nM<br />
nicot<strong>in</strong>e (10 µM)<br />
nicot<strong>in</strong>e bitartrate salt (IC 50 : 3 nM)<br />
Gopalakrishnan et al.(1996) J. Pharmacol. Exp. Ther., 276: 289-297.<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
α<br />
N neuronal (a4b2) - agonist radioligand<br />
b<strong>in</strong>d<strong>in</strong>g<br />
Ref. 0110<br />
[Custom offer]<br />
Please contact us at:<br />
customresearch@cerep.com<br />
Source<br />
Ligand<br />
Kd<br />
Non specific<br />
Reference<br />
rat cerebral cortex<br />
[ 3 H]cytis<strong>in</strong>e (1.5 nM)<br />
1.8 nM<br />
nicot<strong>in</strong>e (10 µM)<br />
nicot<strong>in</strong>e (IC 50 : 8.7 nM)<br />
Pabreza, L.A. et al. (1991) Mol. Pharmacol., 39: 9-12.<br />
specific b<strong>in</strong>d<strong>in</strong>g (% of control)<br />
100<br />
<br />
<br />
50 <br />
<br />
nicot<strong>in</strong>e<br />
carbachol<br />
atrop<strong>in</strong>e<br />
0<br />
α-bungarotox<strong>in</strong><br />
<br />
-10 -8 -7 -6 -5 -4 -9 -3<br />
log [drug] (M) <br />
<br />
<br />
N neuronal (a7) - antagonist radioligand<br />
b<strong>in</strong>d<strong>in</strong>g<br />
Ref. 0567<br />
[Custom offer]<br />
Please contact us at:<br />
customresearch@cerep.com<br />
Source<br />
Ligand<br />
Kd<br />
Non specific<br />
Reference<br />
rat cerebral cortex<br />
[ 125 I]α-bungarotox<strong>in</strong> (1 nM)<br />
0.3 nM<br />
α-bungarotox<strong>in</strong> (1 µM)<br />
α-bungarotox<strong>in</strong> (IC 50 : 1.7 nM)<br />
Sharples, C.G.V. et al. (2000) J. Neurosci., 20: 2783-2791.<br />
specific b<strong>in</strong>d<strong>in</strong>g (% of control)<br />
100<br />
50<br />
0<br />
<br />
-10 -9 -7 -6 -5 -4 -3<br />
-11 -8<br />
log [drug] (M)<br />
α-bungarotox<strong>in</strong><br />
epibatid<strong>in</strong>e<br />
tubocurar<strong>in</strong>e<br />
nicot<strong>in</strong>e<br />
N neuronal (a7) - antagonist radioligand<br />
Source<br />
SH-SY5Y cells (endogenous)<br />
Ligand<br />
[ 125 I]α-bungarotox<strong>in</strong><br />
b<strong>in</strong>d<strong>in</strong>g<br />
Kd (nM) 0.34 nM<br />
Ref. 3010<br />
Non specific α-bungarotox<strong>in</strong> (1 µM)<br />
Q 3 weeks<br />
Reference α-bungarotox<strong>in</strong> (IC 50 : 2.1 nM)<br />
Included <strong>in</strong>:<br />
Organ safety profile<br />
Sharples et al.(2000) J. Neurosci., 20: 2783-2791.<br />
<br />
<br />
<br />
α<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
For further details and updated <strong>in</strong>formation on assays:<br />
❚ Please go to www.cerep.com catalog onl<strong>in</strong>e or contact us at sales@cerep.com<br />
<br />
<br />
<br />
❚ Europe: +33 (0)5 49 89 30 00 – USA: +1 (425) 895 8666 – Japan: +81 (0)3 3354 4026 – Ch<strong>in</strong>a: +86 21 5132 0568<br />
Assay developed <strong>in</strong> 2010 New assay conditions Human Q Standard turnaround time